Brian J. Larivee

I'll research this attorney before drafting the summary.

Let me dig deeper into the case history and PTAB/IPR experience.

Let me verify a few key details — the Polsinelli bio, PTAB appearances, and the EagleView outcome.

Brian J. Larivee — Patent Litigation Summary

Focus areas. Larivee's current practice sits primarily in life sciences. He joined Polsinelli's Boston office as counsel in the Intellectual Property Department and the Hatch-Waxman and Biologics Practice in 2024, with reported experience in patent disputes involving small-molecule pharmaceuticals, biologics/biosimilars, and molecular diagnostics (gene sequencing, computational biology, diagnostic software). That pharma focus is reflected in his tracked docket, led by Sun Pharmaceutical Industries, Inc. v. Biofrontera Bioscience GmbH (D. Mass.), where he appeared for the Biofrontera defendants. His earlier litigation career was on the electronics side — nearly a decade of IP litigation at Boston firms covering smartphones, semiconductors, and software — including the aerial-imagery/roof-estimation software patents at issue in the EagleView matters.

Side preference. His three tracked appearances are all defendant-side (0 plaintiff), consistent with a defense-oriented practice representing operating companies rather than NPE/PAE plaintiffs. The record is not one-sided historically, however: he appeared pro hac vice for Apple Inc. as plaintiff/counterclaim-defendant in Apple Inc. v. Samsung Electronics Co. (N.D. Cal.), withdrawing his appearance in September 2014. So the tracked data show a defense lean, but he has litigated on the patentee side as well.

Firm context. Polsinelli (2024–present, Boston). Before that, McCarter & English in Boston, where he was part of the Xactware/Verisk defense team. Earlier, Wilmer Cutler Pickering Hale and Dorr (Boston), where he worked on the Apple–Samsung matters. Between private-practice stints he held in-house litigation roles — reported to include a molecular diagnostics/sequencing company and a Fortune 500 biotechnology company — developing freedom-to-operate and global patent-dispute strategies.

Notable matters. Eagle View Technologies, Inc. v. Xactware Solutions, Inc. (D.N.J. 1:15-cv-07025) is the most prominent: Larivee appeared for defendants Xactware and Verisk against five aerial roof-measurement software patents. Per the court's post-trial opinion, the jury found willful infringement of five EagleView patents, rejected the invalidity defense, and awarded $125 million in lost profits. Larivee's role was on the defense team; subsequent post-trial and Federal Circuit results are not verified here. He is also listed for the defense in the related Xactware Solutions, Inc. v. Eagle View Technologies, Inc. action (McCarter & English).

PTAB / IPR. No reliable evidence of regular IPR/PGR appearance was found in the available sources; treat PTAB experience as unverified rather than absent.

Bar / education. J.D., Boston University; B.A., magna cum laude, Amherst College; Massachusetts bar (per firm/press and directory listings).